Clinical trials

Safety Profile of Psilocybin for Cocaine Use Disorder (opens ClinicalTrials.gov in a new tab)

Suspended Early Phase 1 10 participants University of California, Los Angeles

Cocaine Use Disorder

Psilocybin After Trauma Surgery for Pain (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 70 participants Trent Emerick

Pain Management, Postoperative Pain

Effectiveness of the Mindful Compassion Care Program for Healthcare Professionals in Oncology and Palliative Care (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 160 participants Azienda USL Reggio Emilia - IRCCS

Professional Quality of Life, Palliative Care, Oncology

Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 90 participants Massachusetts General Hospital

Repetitive Negative Thinking, Serious Mental Illness Symptoms

Mindfulness Therapy for Chronic Pain After Intimate Partner Violence (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 58 participants Brigham and Women's Hospital

Chronic Pain

Virtual Reality-based Mindfulness Training for Mental Health After Stroke (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 48 participants Nicolas Nicastro

Stroke (Subacute)

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Withdrawn Phase 2 0 participants Johns Hopkins University

Opioid Use Disorder

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 17 participants City of Hope Medical Center

Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Inhaled Cannabis for Treatment of PTSD (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 320 participants Multidisciplinary Association for Psychedelic Studies

Post Traumatic Stress Disorder PTSD

Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention Development (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 60 participants VA Office of Research and Development

Stress Disorders, Post-Traumatic, Marijuana Abuse

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 450 participants Duke University

Critical Illness, Heart Failure, Sepsis, Ards

Group PACBT for Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants University of California, Los Angeles

Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy

Comparative Effects of Four Brief Breathwork and Mindfulness Interventions on Anxiety and Psychological Flexibility: A 4-Arm RCT (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 240 participants Valencian International University (VIU)

Anxiety, Psychological Flexibility, Stress

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 50 participants Charles Raison

Aging, Longevity, Biomarkers of Aging

Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 100 participants National Institute on Drug Abuse (NIDA)

Cannabis Use Disorder

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 83 participants M.D. Anderson Cancer Center

Psilocybin, Neuropathy

Psilocybin Therapy for Methamphetamine Use Disorder and HIV (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants Nicky Mehtani, MD, MPH

Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV)

Robot-Assisted Meditation for Older Adults With Cognitive Concerns (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 100 participants Johns Hopkins University

Cognitive Impairment, Sleep

Effectiveness of Heart Rate Variability Biofeedback Training Versus a Meditation Program in Reducing Stress Levels in University Undergraduate Students (opens ClinicalTrials.gov in a new tab)

Withdrawn 0 participants University of Seville

Stress, Anxiety State

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 64 participants University of Alabama at Birmingham

Weight Loss, GLP - 1, Weight Loss Maintenance, Obesity & Overweight

MDMA-AT for PTSD in Young Adults With Childhood Trauma (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 15 participants Jenna M. Traynor

Posttraumatic Stress Disorder (PTSD)

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 200 participants National Institute on Aging (NIA)

Alzheimer's Disease

Mindfulness for Lonely Older Adults With Emigrant Children (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 90 participants Hong Kong Metropolitan University

Loneliness, Sleep Quality, Quality of Life, Stress

Consciousness Studies and Cardiovascular Health (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 40 participants University of Miami

Blood Pressure, Relaxation, Virtual Reality

Mindfulness-Based Substance Use Prevention (MINDS-UP) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 45 participants New York State Psychiatric Institute

Substance Use